269 related articles for article (PubMed ID: 25218987)
1. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
Abdin AA; Hasby EA
Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
[TBL] [Abstract][Full Text] [Related]
2. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
[TBL] [Abstract][Full Text] [Related]
3. Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.
Soleimani M; Jameie SB; Barati M; Mehdizadeh M; Kerdari M
Iran Biomed J; 2014; 18(4):203-11. PubMed ID: 25326018
[TBL] [Abstract][Full Text] [Related]
4. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
5. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
Nath N; Giri S; Prasad R; Singh AK; Singh I
J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
[TBL] [Abstract][Full Text] [Related]
6. The possible anti-apoptotic and antioxidant effects of acetyl l-carnitine as an add-on therapy on a relapsing-remitting model of experimental autoimmune encephalomyelitis in rats.
Zidan A; Hedya SE; Elfeky DM; Abdin AA
Biomed Pharmacother; 2018 Jul; 103():1302-1311. PubMed ID: 29864912
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis.
Rezaei N; Amirghofran Z; Nikseresht A; Ashjazade N; Zoghi S; Tahvili S; Kamali-Sarvestani E
Immunol Invest; 2016 Oct; 45(7):679-91. PubMed ID: 27611715
[TBL] [Abstract][Full Text] [Related]
8. The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Leva G; Klein C; Benyounes J; Hallé F; Bihel F; Collongues N; De Seze J; Mensah-Nyagan AG; Patte-Mensah C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3016-3027. PubMed ID: 28899788
[TBL] [Abstract][Full Text] [Related]
9. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D
Haghmorad D; Yazdanpanah E; Jadid Tavaf M; Zargarani S; Soltanmohammadi A; Mahmoudi MB; Mahmoudi M
Neurol Res; 2019 Oct; 41(10):943-957. PubMed ID: 31402771
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
12. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
14. Interferon beta1a treatment modulates TH1 expression in gammadelta + T cells from relapsing-remitting multiple sclerosis patients.
Elliott CL; El-Touny SY; Filipi ML; Healey KM; Leuschen MP
J Clin Immunol; 2001 May; 21(3):200-9. PubMed ID: 11403227
[TBL] [Abstract][Full Text] [Related]
15. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
[TBL] [Abstract][Full Text] [Related]
16. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
Axtell RC; de Jong BA; Boniface K; van der Voort LF; Bhat R; De Sarno P; Naves R; Han M; Zhong F; Castellanos JG; Mair R; Christakos A; Kolkowitz I; Katz L; Killestein J; Polman CH; de Waal Malefyt R; Steinman L; Raman C
Nat Med; 2010 Apr; 16(4):406-12. PubMed ID: 20348925
[TBL] [Abstract][Full Text] [Related]
17. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
18. Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
Martín R; Hernández M; Córdova C; Nieto ML
Br J Pharmacol; 2012 Jul; 166(5):1708-23. PubMed ID: 22260389
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis.
Benou C; Wang Y; Imitola J; VanVlerken L; Chandras C; Karalis KP; Khoury SJ
J Immunol; 2005 May; 174(9):5407-13. PubMed ID: 15843539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
